Delivery Order SPE2DB22D3009-SPE2DB25FAW02
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ferric Citrate 210 mg tablets (200-count packages) with a contract value of $1,224.62. This non-set-aside, competitively awarded delivery order represents a firm fixed-price procurement scheduled for completion by April 25, 2025. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ferric Citrate 210 mg tablets (200-count units) with a ceiling value of $1,260.03. This firm fixed-price delivery order, which is due for completion by August 11, 2025, represents a non-competitive award issued under the company's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ferric Citrate 210 mg tablets in a quantity of 200 units, with a contract ceiling value of $4,653.89. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a $6,005.11 firm fixed price delivery order to AmerisourceBergen Drug Corp for 200 tablets of Ferric Citrate 210 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside award was competitively procured and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Ferric citrate is an FDA-approved iron replacement therapy used to treat iron deficiency anemia in patients with chronic...
- The Defense Logistics Agency awarded a delivery order valued at $22,345.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and an ultimate completion date of July 21, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials with a ceiling value of $2,321.19 and an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric iron supplement procurement supporting federal medical supply requirements. The contract was fulfilled by AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,262.01 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Feraheme 510 mg/17 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials, with a ceiling value of $1,491.43 and an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $11,624.29 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $9,699.44 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on September 10, 2025, with completion expected by September 11, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FAW02Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,301.19 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ferric Citrate 210 mg tablets (200-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. As a child contract, this delivery order draws from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of medications and medical supplies to support Defense Health Agency and other government healthcare systems. The company's federal contract awards demonstrate consistent capability to fulfill competitive procurement requirements across a wide spectrum of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies. This particular delivery order for Ferric Citrate, an iron-replacement medication commonly used in nephrology care, represents routine pharmaceutical supply fulfillment under the DLA Medical Supply Chain's pharmaceutical prime vendor framework supporting military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 4/24/25 |